Author details

Full Name

Timothy S Davison

Affiliation

ORCID

Career Start Year

1997

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
31614830	Effective Exploration Behavior for Chemical-Sensing Robots.	Biomimetics	2019
29843806	A computational framework for complex disease stratification from multiple large-scale datasets.	BMC Syst Biol	2018
29981298	Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis.	Gastroenterology	2018
28113023	Reply to L. Casadaban et al.	J Clin Oncol	2017
27353327	Prior knowledge transfer across transcriptional data sets and technologies using compositional statistics yields new mislabelled ovarian cell line.	Nucleic Acids Res	2016
27432924	Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).	J Clin Oncol	2016
26415599	PROKARYO: an illustrative and interactive computational model of the lactose operon in the bacterium Escherichia coli.	BMC Bioinformatics	2015
25960256	Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue.	J Mol Diagn	2015
24402422	Identification and validation of an anthracycline/cyclophosphamide-based chemotherapy response assay in breast cancer.	J Natl Cancer Inst	2014
24077567	Model selection for prognostic time-to-event gene signature discovery with applications in early breast cancer data.	Statistical Applications in Genetics and Molecular Biology	2013
22251612	Implications for powering biomarker discovery studies.	J Mol Diagn	2012
22067406	Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue.	J Clin Oncol	2011
21784052	miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.	Exp Hematol	2011
20676067	A comparison of batch effect removal methods for enhancement of prediction performance using MAQC-II microarray gene expression data.	Pharmacogenomics J	2010
20676074	The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.	Nat Biotechnol	2010
18687792	Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling.	Journal of Molecular Diagnostics	2008
17237814	MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma.	Oncogene	2007
16939783	Analyzing micro-RNA expression using microarrays.	Methods in Enzymology	2006
16964229	The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.	Nat Biotechnol	2006
15806101	A gene expression map of Arabidopsis thaliana development.	Nat Genet	2005
11254385	Structure and functionality of a designed p53 dimer.	J Mol Biol	2001
10944184	A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.	Proc Natl Acad Sci U S A	2000
10373484	p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53.	J Biol Chem	1999
9704931	Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome.	Oncogene	1998
9312059	ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.	EMBO J	1997